These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7830559)

  • 1. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins.
    Domenighini M; Magagnoli C; Pizza M; Rappuoli R
    Mol Microbiol; 1994 Oct; 14(1):41-50. PubMed ID: 7830559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer modelling of the NAD binding site of ADP-ribosylating toxins: active-site structure and mechanism of NAD binding.
    Domenighini M; Montecucco C; Ripka WC; Rappuoli R
    Mol Microbiol; 1991 Jan; 5(1):23-31. PubMed ID: 1901617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADP-ribosylating toxins.
    Passador L; Iglewski W
    Methods Enzymol; 1994; 235():617-31. PubMed ID: 8057931
    [No Abstract]   [Full Text] [Related]  

  • 4. The best defense is a good offense--Salmonella deploys an ADP-ribosylating toxin.
    Lesnick ML; Guiney DG
    Trends Microbiol; 2001 Jan; 9(1):2-4; discussion 4-5. PubMed ID: 11166220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
    Wilson BA; Collier RJ
    Curr Top Microbiol Immunol; 1992; 175():27-41. PubMed ID: 1628498
    [No Abstract]   [Full Text] [Related]  

  • 6. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin.
    Lobet Y; Cluff CW; Cieplak W
    Infect Immun; 1991 Sep; 59(9):2870-9. PubMed ID: 1908825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.
    Li M; Dyda F; Benhar I; Pastan I; Davies DR
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6902-6. PubMed ID: 8692916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.
    Jørgensen R; Merrill AR; Yates SP; Marquez VE; Schwan AL; Boesen T; Andersen GR
    Nature; 2005 Aug; 436(7053):979-84. PubMed ID: 16107839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases.
    Han S; Tainer JA
    Int J Med Microbiol; 2002 Feb; 291(6-7):523-9. PubMed ID: 11890553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant microbial ADP-ribosylating toxins of Bordetella pertussis, Vibrio cholerae, and enterotoxigenic Escherichia coli: structure, function, and toxoid vaccine development.
    Burnette WN; Cieplak W; Kaslow HR; Rappuoli R; Tuomanen EI
    Bioprocess Technol; 1994; 19():185-203. PubMed ID: 7764758
    [No Abstract]   [Full Text] [Related]  

  • 12. AB5 ADP-ribosylating toxins: comparative anatomy and physiology.
    Burnette WN
    Structure; 1994 Mar; 2(3):151-8. PubMed ID: 8069630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. His-426 of the Pseudomonas aeruginosa exotoxin A is required for ADP-ribosylation of elongation factor II.
    Wozniak DJ; Hsu LY; Galloway DR
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8880-4. PubMed ID: 3143111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit.
    Locht C; Antoine R
    Biochimie; 1995; 77(5):333-40. PubMed ID: 8527486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of histidine 35 of the S1 subunit of pertussis toxin in the ADP-ribosylation of transducin.
    Xu Y; Barbançon-Finck V; Barbieri JT
    J Biol Chem; 1994 Apr; 269(13):9993-9. PubMed ID: 8144593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli.
    Sixma TK; Pronk SE; Kalk KH; Wartna ES; van Zanten BA; Witholt B; Hol WG
    Nature; 1991 May; 351(6325):371-7. PubMed ID: 2034287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue.
    Han XY; Galloway DR
    J Biol Chem; 1995 Jan; 270(2):679-84. PubMed ID: 7822295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the enzymatic active site of Pseudomonas aeruginosa exotoxin A.
    Brandhuber BJ; Allured VS; Falbel TG; McKay DB
    Proteins; 1988; 3(3):146-54. PubMed ID: 3151219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of a new heat-labile enterotoxin, LT-IIb.
    van den Akker F; Sarfaty S; Twiddy EM; Connell TD; Holmes RK; Hol WG
    Structure; 1996 Jun; 4(6):665-78. PubMed ID: 8805549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A binding motif for Hsp90 in the A chains of ADP-ribosylating toxins that move from the endoplasmic reticulum to the cytosol.
    Kellner A; Taylor M; Banerjee T; Britt CBT; Teter K
    Cell Microbiol; 2019 Oct; 21(10):e13074. PubMed ID: 31231933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.